Cash and Cash Equivalents, at Carrying Value of BriaCell Therapeutics Corp. from 31 Jul 2021 to 31 Jan 2026

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
BriaCell Therapeutics Corp. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Jul 2021 to 31 Jan 2026.
  • BriaCell Therapeutics Corp. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Jan 2026 was $29,903,628, a 496% increase year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

BriaCell Therapeutics Corp. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $29,903,628 +$24,889,974 +496% 31 Jan 2026 10-Q 10 Mar 2026 2026 Q2
Q3 2025 $2,714,012 -$3,078,253 -53% 31 Oct 2025 10-Q 11 Dec 2025 2026 Q1
Q2 2025 $10,493,808 +$9,631,719 +1117% 31 Jul 2025 10-Q 10 Mar 2026 2026 Q2
Q1 2025 $12,460,253 +$11,524,559 +1232% 30 Apr 2025 10-Q 16 Jun 2025 2025 Q3
Q4 2024 $5,013,654 -$1,230,874 -20% 31 Jan 2025 10-Q 12 Mar 2025 2025 Q2
Q3 2024 $5,792,265 -$7,853,582 -58% 31 Oct 2024 10-Q 16 Dec 2024 2025 Q1
Q2 2024 $862,089 -$20,389,003 -96% 31 Jul 2024 10-K 16 Oct 2025 2025 FY
Q1 2024 $935,694 -$27,234,405 -97% 30 Apr 2024 10-Q 14 Jun 2024 2024 Q3
Q4 2023 $6,244,528 -$27,255,708 -81% 31 Jan 2024 10-Q 18 Mar 2024 2024 Q2
Q3 2023 $13,645,847 -$23,806,129 -64% 31 Oct 2023 10-Q 14 Dec 2023 2024 Q1
Q2 2023 $21,251,092 -$19,790,560 -48% 31 Jul 2023 10-K 29 Oct 2024 2024 FY
Q1 2023 $28,170,099 30 Apr 2023 10-Q 14 Jun 2023 2023 Q3
Q4 2022 $33,500,236 31 Jan 2023 10-Q 16 Mar 2023 2023 Q2
Q3 2022 $37,451,976 31 Oct 2022 10-Q 14 Dec 2022 2023 Q1
Q2 2022 $41,041,652 -$16,227,033 -28% 31 Jul 2022 10-K 25 Oct 2023 2023 FY
Q2 2021 $57,268,685 31 Jul 2021 10-K 28 Oct 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.